scholarly journals Genetic and Phenotypic Properties of Vero Cell-Adapted Japanese Encephalitis Virus SA14-14-2 Vaccine Strain Variants and a Recombinant Clone, Which Demonstrates Attenuation and Immunogenicity in Mice

2015 ◽  
Vol 92 (1) ◽  
pp. 98-107 ◽  
Author(s):  
Gregory D. Gromowski ◽  
Stephen S. Whitehead ◽  
José Bustos-Arriaga ◽  
Cai-Yen Firestone
PLoS ONE ◽  
2016 ◽  
Vol 11 (3) ◽  
pp. e0150213 ◽  
Author(s):  
Akira Higuchi ◽  
Hiroko Toriniwa ◽  
Tomoyoshi Komiya ◽  
Tetsuo Nakayama

Vaccine ◽  
2008 ◽  
Vol 26 (34) ◽  
pp. 4382-4386 ◽  
Author(s):  
E. Schuller ◽  
B. Jilma ◽  
V. Voicu ◽  
G. Golor ◽  
H. Kollaritsch ◽  
...  

Author(s):  
Rong Huang ◽  
Shengling Leng ◽  
Yalan Feng ◽  
Liping Tang ◽  
Lei Yuan ◽  
...  

The attenuated Japanese encephalitis virus (JEV) live vaccine SA14-14-2 prepared from wild-type (WT) strain SA14 was licensed to prevent Japanese encephalitis (JE) in 1989 in China. Many studies showed that the premembrane (prM) and envelope (E) protein were the crucial determinant of virulence and immunogenicity of JEV. So we are interested in whether the substitution of prM/E of JEV WT SA14 with those of vaccine strain SA14-14-2 could decrease neurovirulence and prevent the challenge of JEV WT SA14. Molecular clone technique was used to replace the prM/E gene of JEV WT strain SA14 with those of vaccine strain SA14-14-2 to construct the infectious clone of chimeric virus (designated JEV SA14/SA14-14-2), the chimeric virus recovered from BHK21 cells upon electrotransfection of RNA into BHK21 cells. The results showed that the recovered chimeric virus was highly attenuated in mice, and a single immunization elicited strong protective immunity in a dose-dependent manner. This study increases our understanding of the molecular mechanisms of neurovirulence attenuation and immunogenicity of JEV.


Vaccine ◽  
2011 ◽  
Vol 29 (47) ◽  
pp. 8669-8676 ◽  
Author(s):  
Elisabeth Schuller ◽  
Anton Klingler ◽  
Katrin Dubischar-Kastner ◽  
Shailesh Dewasthaly ◽  
Zsuzsanna Müller

2020 ◽  
Author(s):  
Vaseef A. Rizvi ◽  
Maharnob Sarkar ◽  
Rahul Roy

AbstractJapanese encephalitis virus (JEV), a neurotropic flavivirus, is the leading cause of viral encephalitis in endemic regions of Asia. Although the mechanisms modulating JEV virulence and neuroinvasiveness are poorly understood, several acquired mutations in the live attenuated vaccine strain (SA14-14-2) point towards translation regulation as a key strategy. Using ribosome profiling, we identify multiple mechanisms including frameshifting, tRNA dysregulation and alternate translation initiation sites that regulate viral protein synthesis. A significant fraction (~ 40%) of ribosomes undergo frameshifting on NS1 coding sequence leading to early termination, translation of NS1′ protein and modulation of viral protein stoichiometry. Separately, a tRNA subset (glutamate, serine, leucine and histidine) was found to be associated in high levels with the ribosomes upon JEV infection. We also report a previously uncharacterised translational initiation event from an upstream UUG initiation codon in JEV 5′ UTR. A silent mutation at this start site in the vaccine strain has been shown to abrogate neuroinvasiveness suggesting the potential role of translation from this region. Together, our study sheds light on distinct mechanisms that modulate JEV translation with likely consequences for viral pathogenesis.


Sign in / Sign up

Export Citation Format

Share Document